References
- Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J. Clin.68 ( 6 ), 394 – 424 ( 2018 ).
- Wise J . Diagnosing cancer early is vital, new figures show . BMJ353 , i3277 ( 2016 ).
- Hubenak JR Zhang Q Branch CD Kronowitz SJ . Mechanisms of injury to normal tissue after radiotherapy: a review . Plast. Reconstr. Surg.133 ( 1 ), 49e – 56e ( 2014 ).
- Bobo D Robinson KJ Islam J Thurecht KJ Corrie SR . Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date . Pharm. Res.33 ( 10 ), 2373 – 2387 ( 2016 ).
- Ventola CL . Progress in nanomedicine: approved and investigational nanodrugs . P T42 ( 12 ), 742 – 755 ( 2017 ).
- Tayo LL . Stimuli-responsive nanocarriers for intracellular delivery . Biophys. Rev.9 ( 6 ), 931 – 940 ( 2017 ).
- Sharma M Dube T Chibh S Kour A Mishra J Panda JJ . Nanotheranostics, a future remedy of neurological disorders . Expert Opin. Drug Deliv.doi: 10.1080/17425247.2019.1562443 ( 2018 ) ( Epub ahead of print ).
- Ajdary M Moosavi MA Rahmati M et al. Health concerns of various nanoparticles: a review of their in vitro and in vivo toxicity . Nanomaterials (Basel) , 8 ( 9 ), 634 – 661 ( 2018 ).
- Elsabahy M Wooley KL . Design of polymeric nanoparticles for biomedical delivery applications . Chem. Soc. Rev.41 ( 7 ), 2545 – 2561 ( 2012 ).
- Hamley IW . Small bioactive peptides for biomaterials design and therapeutics . Chem. Rev.117 ( 24 ), 14015 – 14041 ( 2017 ).
- Habibi N Kamaly N Memic A Shafiee H . Self-assembled peptide-based nanostructures: smart nanomaterials toward targeted drug delivery . Nano Today11 ( 1 ), 41 – 60 ( 2016 ).
- Tesauro D Accardo A Diaferia C et al. Peptide-based drug-delivery systems in biotechnological applications: recent advances and perspectives . Molecules24 ( 2 ), 351 ( 2019 ).
- Yu CY Huang W Li ZP Lei XY He DX Sun L . Progress in self-assembling peptide-based nanomaterials for biomedical applications . Curr. Top. Med. Chem.16 ( 3 ), 281 – 290 ( 2016 ).
- Schnaider L Brahmachari S Schmidt NW et al. Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity . Nat. Commun.8 ( 1 ), 1365 ( 2017 ).
- Panda JJ Mishra J . Self-assembled dipeptide-based nanostructures: tiny tots with great applications . Ther. Deliv.7 ( 2 ), 59 – 62 ( 2016 ).
- Panda JJ Kaul A Kumar S et al. Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery . Nanomedicine (Lond) , 8 ( 12 ), 1927 – 1942 ( 2013 ).
- Gorbitz CH . The structure of nanotubes formed by diphenylalanine, the core recognition motif of Alzheimer’s beta-amyloid polypeptide . Chem. Commun. (Camb) , ( 22 ), 2332 – 2334 ( 2006 ).
- Singh PK Chibh S Dube T Chauhan VS Panda JJ . Arginine-alpha, beta-dehydrophenylalanine dipeptide nanoparticles for pH-responsive drug delivery . Pharm. Res.35 ( 2 ), 35 ( 2018 ).
- Viale M Tosto R Giglio V et al. Cyclodextrin polymers decorated with RGD peptide as delivery systems for targeted anti-cancer chemotherapy . Invest. New Drugsdoi: 10.1007/s10637-018-0711-9 ( 2018 ) ( Epub ahead of print ).
- Fang Z Sun Y Xiao H et al. Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle . Biomed. Pharmacother.85 , 160 – 168 ( 2017 ).
- Guo Z Zhou X Xu M Tian H Chen X Chen M . Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability . Biomater. Sci.5 ( 12 ), 2501 – 2510 ( 2017 ).
- Haddad T Qin R Lupu R et al. A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors . Cancer Chemother. Pharmacol.79 ( 6 ), 1221 – 1227 ( 2017 ).
- Stupp R Hegi ME Gorlia T et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, Phase III trial . Lancet Oncol.15 ( 10 ), 1100 – 1108 ( 2014 ).
- Tsume Y Drelich AJ Smith DE Amidon GL . Potential development of tumor-targeted oral anti-cancer prodrugs: amino acid and dipeptide monoester prodrugs of gemcitabine . Molecules22 ( 8 ), 1322 – 1377 ( 2017 ).